IC
ALXO icon

IEQ Capital’s ALX Oncology ALXO Stock Holding History

IEQ Capital’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
175,382
+83,149
+90% +$149K ﹤0.01% 1553
2026
Q1 		$185K Hold
92,233
– – ﹤0.01% 1713
2025
Q4 		$104K Hold
92,233
– – ﹤0.01% 1758
2025
Q3 		$169K Buy
+92,233
New +$79.9K ﹤0.01% 1704

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

IEQ Capital's ALXO Position: Q2 2026 in Review

IEQ Capital increased its ALX Oncology (ALXO) stake by 90% in Q2 2026, buying an estimated $149K and bringing the position to 175,382 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #1553.

IEQ Capital first reported a position in ALXO in Q3 2025 and has held it in 4 quarters since. 94 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • IEQ Capital held 175,382 shares of ALX Oncology worth $363K as of Q2 2026.
  • IEQ Capital bought 83,149 ALX Oncology shares in Q2 2026, an estimated $149K.
  • ALX Oncology made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1553 holding.
  • IEQ Capital first reported a position in ALX Oncology in Q3 2025 and has held it in 4 quarters since.
  • 94 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.